Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value: $2.227B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $312M | 14.0% | $39.31 | +69.6% | Common | 00166B105 |
| — | Instil Bio Inc | 12,486,787 | $223M | 10.0% | $25.08 | — | Common | 45783C101 |
| HRMY | Harmony Biosciences Holdings Inc | 4,884,341 | $187M | 8.4% | $36.16 | -10.9% | Common | 413197104 |
| — | New Frontier Health Corp | 14,300,000 | $161M | 7.2% | $8.25 | — | Ord Shs | G6461G106 |
| — | Amyris, Inc | 11,642,195 | $160M | 7.2% | $3.12 | — | Common | 03236M200 |
| ASND | Ascendis Pharma A/S | 760,606 | $121M | 5.4% | $112.61 | — | SPONSORED ADR | 04351P101 |
| — | Iveric Bio Inc | 5,966,527 | $96.9M | 4.4% | $5.10 | — | Common | 46583P102 |
| — | Genetron Holdings Ltd | 6,339,860 | $87.81M | 3.9% | $12.07 | — | ADS | 37186H100 |
| TARS | Tarsus Pharmaceuticals Inc | 2,987,331 | $64.38M | 2.9% | $28.48 | -13.1% | Common | 87650L103 |
| — | Aligos Therapeutics Inc | 3,547,030 | $55.01M | 2.5% | $27.65 | — | Common | 01626L105 |
| — | Bolt Therapeutics Inc | 3,871,291 | $48.97M | 2.2% | $32.91 | — | Common | 097702104 |
| — | Sierra Oncology, Inc | 1,917,074 | $42.02M | 1.9% | $10.67 | — | Common | 82640U404 |
| WHWK | Aadi Bioscience Inc | 1,427,213 | $41.92M | 1.9% | $30.48 | 0.0% | Common | 00032Q104 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 1.7% | $6.47 | 0.0% | SHS | P8696W104 |
| — | Kadmon Holdings Inc | 4,283,014 | $37.3M | 1.7% | $4.19 | — | Common | 48283N106 |
| — | Impel NeuroPharma Inc | 2,884,789 | $35.14M | 1.6% | $8.85 | — | Common | 45258K109 |
| OLMA | Olema Pharmaceuticals Inc | 1,238,575 | $34.13M | 1.5% | $46.89 | -42.4% | Common | 68062P106 |
| — | Avadel Pharmaceuticals PLC | 2,937,093 | $28.78M | 1.3% | $7.94 | — | ADR | 05337M104 |
| KALV | KalVista Pharmaceuticals Inc. | 1,641,913 | $28.65M | 1.3% | $15.45 | +31.2% | Common | 483497103 |
| TERN | Terns Pharmaceuticals Inc | 2,675,133 | $27.88M | 1.3% | $21.92 | -52.7% | Common | 880881107 |
| CLDX | Celldex Therapeutics Inc | 484,453 | $26.16M | 1.2% | $4.95 | +848.0% | Common | 15117B202 |
| LEGN | Legend Biotech Corp Sponsored | 488,751 | $24.71M | 1.1% | $42.56 | — | SPONSORED ADS | 52490G102 |
| VRDN | Viridian Therapeutics Inc | 1,300,000 | $21.39M | 1.0% | $14.67 | 0.0% | Common | 92790C104 |
| SERA | Sera Prognostics Inc | 1,856,011 | $20.62M | 0.9% | $10.38 | 0.0% | Common | 81749D107 |
| ZLAB | Zai Lab Ltd ADR | 174,999 | $18.44M | 0.8% | $76.83 | — | ADR | 98887Q104 |
| ACRS | Aclaris Therapeutics, Inc. | 940,754 | $16.93M | 0.8% | $1.36 | +1077.7% | Common | 00461U105 |
| MREO | Mereo Biopharma Group PLC | 6,907,189 | $16.71M | 0.8% | $2.58 | — | ADS | 589492107 |
| — | Verona Pharma PLC | 2,749,918 | $15.07M | 0.7% | $5.20 | — | ADS | 925050106 |
| NKTX | Nkarta Inc | 512,225 | $14.24M | 0.6% | $29.47 | +7.5% | Common | 65487U108 |
| — | Dice Therapeutics Inc | 410,000 | $13.43M | 0.6% | $32.75 | — | Common | 23345J104 |
| — | Gracell Biotechnologies Inc | 961,359 | $13.33M | 0.6% | $15.40 | — | SPONSORED ADS | 38406L103 |
| — | Curis Inc | 1,553,500 | $12.16M | 0.5% | $8.50 | — | Common | 231269200 |
| COGT | Cogent Biosciences Inc | 1,420,941 | $11.95M | 0.5% | $7.66 | 0.0% | Common | 19240Q201 |
| — | Chinook Therapeutics Inc | 872,151 | $11.13M | 0.5% | $15.86 | — | Common | 16961L106 |
| AUPH | Aurinia Pharmaceuticals Inc. | 500,732 | $11.08M | 0.5% | $17.64 | -10.0% | Common | 05156V102 |
| CRNX | Crinetics Pharmaceuticals Inc | 517,280 | $10.89M | 0.5% | $20.29 | +3.1% | Common | 22663K107 |
| ARQT | Arcutis Biotherapeutics Inc | 433,585 | $10.36M | 0.5% | $26.87 | -15.1% | Common | 03969K108 |
| KURA | Kura Oncology Inc | 525,262 | $9.838M | 0.4% | $14.42 | +30.6% | Common | 50127T109 |
| — | Merus NV | 442,000 | $9.724M | 0.4% | $21.00 | — | Common | N5749R100 |
| DYN | Dyne Therapeutics Inc | 577,642 | $9.381M | 0.4% | $20.78 | -14.7% | Common | 26818M108 |
| CDXS | Codexis, Inc | 388,144 | $9.028M | 0.4% | $13.98 | +69.3% | Common | 192005106 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $8.579M | 0.4% | $40.33 | +60.5% | Common | 04280A100 |
| — | Essa Pharma Inc | 1,056,067 | $8.449M | 0.4% | $9.69 | — | Common | 29668H708 |
| — | Zymeworks Inc | 286,064 | $8.307M | 0.4% | $35.47 | — | Common | 98985W102 |
| DSGN | Design Therapeutics | 530,991 | $7.8M | 0.4% | $31.14 | -46.6% | Common | 25056L103 |
| — | Homology Medicines, Inc. | 853,143 | $6.714M | 0.3% | $15.54 | — | Common | 438083107 |
| VALN | Valneva SE | 200,000 | $6.28M | 0.3% | $26.35 | — | SPONSORED ADS | 92025Y103 |
| SNDX | Syndax Pharmaceuticals Inc | 320,000 | $6.115M | 0.3% | $22.59 | -26.2% | Common | 87164F105 |
| — | Satsuma Pharmaceuticals Inc | 1,232,394 | $5.743M | 0.3% | $5.91 | — | Common | 80405P107 |
| — | Passage Bio Inc | 539,263 | $5.371M | 0.2% | $15.75 | — | Common | 702712100 |
| — | Aslan Pharmaceuticals Ltd | 2,840,909 | $5.057M | 0.2% | $3.35 | — | ADS | 04522R101 |
| LRMR | Larimar Therapeutics Inc | 399,830 | $4.61M | 0.2% | $11.65 | +3.0% | Common | 517125100 |
| — | Elevation Oncology Inc | 496,843 | $3.87M | 0.2% | $13.57 | — | Common | 28623U101 |
| — | Eiger BioPharmaceuticals Inc | 469,588 | $3.137M | 0.1% | $6.80 | — | Common | 28249U105 |
| — | Orchard Therapeutics plc | 1,325,736 | $3.049M | 0.1% | $7.53 | — | ADS | 68570P101 |
| TXG | 10X Genomics Inc | 14,798 | $2.154M | 0.1% | $145.11 | +18.3% | CL A Common | 88025U109 |
| — | Precision Biosciences Inc | 140,255 | $1.619M | 0.1% | $6.03 | — | Common | 74019P108 |
| — | Zogenix Inc | 105,000 | $1.595M | 0.1% | $22.77 | — | Common | 98978L204 |
| — | Tricida, Inc. | 167,863 | $779K | 0.0% | $22.00 | — | Common | 89610F101 |
| — | Metacrine Inc | 146,426 | $502K | 0.0% | $10.21 | — | Common | 59101E103 |